Concepedia
Statistics
Publications
70
Citations
4.2K
H-Index
35
Active since
1986
Affiliations
Abbott Fund(Current)
Abbott (United States)
Abbott (United Kingdom)
Terry J. Opgenorth is an author at Abbott Fund specializing in medicine, pharmacology, and physiology.
Top concepts
MedicinePharmacologyPhysiologyVascular BiologyMolecular PharmacologyBiochemistryPharmacotherapyDrug DiscoveryNatural SciencesMedicinal Chemistry
Publications per year
1986–2007
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice
Bradley A. Zinker, Cristina M. Rondinone, James M. Trevillyan et al. · Proceedings of the National Academy of Sciences · 2002 · 412 citations · Full text
Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
J. Bradley Nelson, Kirk M. Chan‐Tack, Sean P. Hedican et al. · PubMed · 1996 · 333 citations
Urology, Prostate Cancer Growth, Endocrine-related Cancer +14
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
Terry J. Opgenorth, Andrew Adler, Samuel V. Calzadilla et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 209 citations
New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade
Joel B. Nelson, Son Hoang Nguyen, Jinshyun R. Wu‐Wong et al. · Urology · 1999 · 168 citations
Mechanobiology, Sclerostin, Health Sciences +14
A Novel Endothelin Antagonist, A-127722, Attenuates Ischemic Lesion Size in Rats With Temporary Middle Cerebral Artery Occlusion
Turgut Tatlisumak, Richard A.D. Carano, Kentaro Takano et al. · Stroke · 1998 · 158 citations · Full text
1–5 of 70